儿童川崎病合并轻微脑炎/脑病伴可逆性胼胝体压部病变综合征1例并文献复习

doi:10.19723/j.issn.1671-167X.2022.04.028

摘要/Abstract

摘要：

报道1例川崎病合并轻微脑炎/脑病伴可逆性胼胝体压部病变综合征(mild encephalitis/encephalopathy with a reversible splenial lesion，MERS)患儿的临床诊疗经过，并回顾相关文献报道，总结疾病特点，提高对该病的认识。本例患者为7岁余男孩，持续高热6 d，伴草莓舌、双眼球结膜充血、全身大片红斑样充血样皮疹和颈部淋巴结肿大，符合川崎病诊断标准。丙种球蛋白(2 g/kg)静脉滴注24 h后患儿仍有发热，且出现头痛、嗜睡表现，头颅磁共振成像(magnetic resonance imaging，MRI)显示胼胝体压部局限性梭形肿胀，T1稍低、T2稍高异常信号，扩散加权成像(diffusion-weighted images，DWI)呈明显高信号，表观扩散系数(apparent diffusion coefficient，ADC)图呈明显低信号，提示MERS，予甲泼尼龙2 mg/(kg·d)静脉滴注，数小时后患儿热退，头痛、嗜睡症状消失。1周后复查头颅MRI正常，出院时没有神经系统异常和冠状动脉扩张。共检索到符合条件的外文文献12篇，未检索到中文文献，共报道17例川崎病合并MERS患儿，中位年龄6.5岁(1~14岁)，其中5岁以上儿童11例，合并冠状动脉扩张者4例。所有患儿均有不同程度的意识障碍、幻视、惊厥等神经系统症状，头颅MRI符合MERS影像学改变，经积极治疗, 所有患儿的神经系统症状完全消失，其中13例患儿复查了头颅MRI，影像学改变均恢复正常，所有患儿均未遗留神经系统后遗症。川崎病合并MERS的病例报道非常少见，并发MERS的川崎病多发生在5岁以上年长儿童，头颅MRI检查有助于早期诊断，及时积极治疗可以使MERS病情短期内逆转，不留神经系统后遗症。

关键词: 黏膜皮肤淋巴结综合征, 轻微脑炎/脑病伴可逆性胼胝体压部病变综合征, 儿童

Abstract:

We reported a pediatric case of Kawasaki disease complicated with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) from Beijing Tsinghua Changgung Hospital. The clinical data were retrospectively analyzed and the related literature was reviewed. The clinical features, treatment and prognosis of the disease were summarized to improve recognition of Kawasaki disease complicated with MERS. A 7-year-old boy was diagnosed with Kawasaki disease due to continuous high fever for 6 d, accompanied by strawberry tongue, conjunctival congestion, erythema-like hyperemia rash, and cervical enlarged lymph nodes. And treatment was started with intravenous immunoglobulin (IVIG: 2 g/kg) and oral aspirin [40 mg/(kg·d)]. Twenty-four hours after the treatment of IVIG, the patient' s fever persisted and in addition he developed headache and drowsiness. His cranial magnetic resonance imaging (MRI) demonstrated a localized lesion in the splenium of the corpus callosum with high intensity signal on diffusion-weighted images (DWI) and T2-weighted, and low intensity signal on apparent diffusion coefficient (ADC) and T1-weighted. Based on these findings, he was diagnosed with MERS-complicated Kawasaki disease. Methylprednisolone [2 mg/(kg·d)] treatment was started intravenously, and within several hours he was afebrile and the neurological symptoms disappeared. A follow-up MRI was conducted after 1 week was normal. He was discharged without any neurological sequelae and coronary artery lesions. A total of 12 qualified foreign literature were retrieved, with no Chinese literature searched. Seventeen children were reported, the median age was 6.5 years (range: 1-14 years), among them 11 cases were children over 5 years old, and 4 cases were complicated with coronary artery lesions. All children had neurological symptoms, such as consciousness disorder, visual hallucination or convulsion. MRI conformed to MERS imaging changes. After active treatment, the neurological manifestations and radiological abnormalities completely disappeared, leaving no neurological sequelae. Kawasaki disease complicated with MERS had not been reported in China by now. Literature that identified Kawasaki disease complicated with MERS mostly occurred in children over 5 years old. Cranial MRI examination is helpful for early diagnosis. Timely treatment can reverse MERS in a short time, without neurological sequelae left.

Key words: Mucocutaneous lymph node syndrome, Mild encephalitis/encephalopathy with a reversible splenial lesion, Child

中图分类号:

R729

杜燕燕,王健,贺兰,季丽娜,徐樨巍. 儿童川崎病合并轻微脑炎/脑病伴可逆性胼胝体压部病变综合征1例并文献复习[J]. 北京大学学报（医学版）, 2022, 54(4): 756-761.

Yan-yan DU,Jian WANG,Lan HE,Li-na JI,Xi-wei XU. Kawasaki disease complicated with mild encephalitis/encephalopathy with a reversible splenial lesion: A case report and literature review[J]. Journal of Peking University (Health Sciences), 2022, 54(4): 756-761.

图/表 2

图1

表1

18例川崎病合并MERS患儿的临床资料"

Case no.	Study	Age/years	Gender	IVIG	Other therapies	Na/(mmol/L)	Consciousness disturbance	Neurological symptom onset	Neurological prognosis	Coronary sequelae
1	Itamura et al^[4]	14	Female	1.8 g/kg	-	128	Headache, visual hallucination, consciousness disorder	Day 5	CR	RCA 8 mm LAD 5.1 mm
2	Sato et al^[5]	7	Female	2g/kg	-	131	Drowsiness, illusion, emotional changes	Day 2	CR	No
3	Takanashi et al^[6]	2	Female	2 g/kg×2 d	PSL	134	Drowsiness, visual hallucination	Day 10	CR	No
4	Takanashi et al^[6]	7	Female	2 g/kg	-	129	Drowsiness, visual hallucination, incoherent speech, impulsive behavior	Day 3	CR	No
5	Takanashi et al^[6]	8	Male	2 g/kg×3 d	CsA, IFX	119	Drowsiness, incoherentspeech, unresponsiveness	Day 1	CR	5 mm(NA)
6	Takanashi et al^[6]	10	Female	2 g/kg×2 d	-	127	Drowsiness, visual hallucination, emotional changes, incoherent speech	Day 3	CR	No
7	Kurokawa et al^[2]	2	Female	2 g/kg×2 d	IVMP, IFX	133	Convulsion, consciousness disorder	Day 2	CR	No
8	Takahashi et al^[7]	2	Male	2 g/kg×2 d	IVMP	133	Convulsion, visual hallucination, consciousness disorder	Day 1	CR	No
9	Tsukamoto et al^[8]	1	Female	2 g/kg×2 d	IVMP	125	Convulsion, cnsciousness disorder	Day 2	CR	No
10	松村et al^[9]	5	Male	2 g/kg	PSL	NA	Consciousness disorder	Day 6	CR	No
11	松村et al^[9]	8	Male	NA	-	NA	Consciousness disorder	Day 5	CR	RCA 3 mm LAD 5 mm
12	八木et al^[10]	11	Female	NA	-	143	Aphasia, ataxia	Day 3	CR	No
13	森et al^[11]	2	Male	NA	IVMP, PE	NA	Drowsiness, consciousness disorder	Day 2	CR	Yes (NA)
14	Yoshihara et al^[12]	2	Female	2 g/kg	IVMP	131	Consciousness disorder, incoherent speech	Day 4	CR	No
15	Kashiwagi et al^[13]	10	Female	NA	IVMP	127	Visual hallucination, incoherent speech, impulsive behavior	Day 2	CR	NA
16	Kashiwagi et al^[13]	6	Male	NA	IVMP	129	Visual hallucination, emotional changes, impulsive behavior, incoherent speech	Day 3	CR	NA
17	Ka et al^[14]	6	Female	2d (NA)	-	NA	Emotional changes, drowsiness	Day 7	CR	NA
18	This study	7	Male	2 g/kg	PSL	128	Headache, drowsiness	Day 8	CR	No

表1

参考文献 26

1	Newburger JW , Takahashi M , Gerber MA , et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Pediatrics, 2004, 114 (6): 1708- 1733. doi: 10.1542/peds.2004-2182
2	Kurokawa Y , Masuda H , Kobayashi T , et al. Effective therapy with infliximab for clinically mild encephalitis/encephalopathy with a reversible splenial lesion in an infant with Kawasaki disease[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2017, 40 (3): 190- 195. doi: 10.2177/jsci.40.190
3	Kobayashi T , Inoue Y , Takeuchi K , et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113 (22): 2606- 2612. doi: 10.1161/CIRCULATIONAHA.105.592865
4	Itamura S , Kamada M , Nakagawa N , et al. Kawasaki disease complicated with reversible splenial lesion and acute myocarditis[J]. Pediatr Cardiol, 2011, 32 (5): 696- 699. doi: 10.1007/s00246-011-9937-4
5	Sato T , Ushiroda Y , Oyama T , et al. Kawasaki disease-associated MERS: Pathological insights from SPECT findings[J]. Brain Dev, 2012, 34 (7): 605- 608. doi: 10.1016/j.braindev.2011.09.015
6	Takanashi J , Shirai K , Sugawara Y , et al. Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS)[J]. J Neurol Sci, 2012, 315 (1/2): 167- 169.
7	Takahashi KI , Homma S , Suzuki K , et al. A case of Kawasaki disease complicated by clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)[J]. J Tokyo Wom Med Univ, 2017, 87 (Suppl 1): 118- 124.
8	Tsukamoto Y , Majima H , Inukai S . A girl of Kawasaki disease associated with MERS after diagnosis of febrile seizure[J]. J Jpn Soc Pediatr Radiol, 2021, 37 (1): 113- 118.
9	松村雄, 阿久津裕子, 倉信大, ほか. 川崎病に合併した脳症の症例報告[J]. 心臓, 2014, 46 (12): 1648- 1649.
10	八木文子, 中田桂, 川上睦美, ほか. Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)2型の2例[J]. 臨床放射線, 2018, 63 (8): 911- 918.
11	森秀洋, 澤田真理子, 佐藤一寿, ほか. 可逆性脳梁膨大部病変を有する軽症脳炎·脳症を合併した川崎病に対する血漿交換療法[J]. 日本小児科学会雑誌, 2020, 124 (10): 1514- 1519.
12	Yoshihara S , Fujita Y , Miyamoto K , et al. Kawasaki disease with mild encephalitis/encephalopathy with reversible splenial lesion in a 2-year-old girl[J]. Indian J Pediatr, 2021, 88 (7): 718. doi: 10.1007/s12098-021-03779-5
13	Kashiwagi M , Tanabe T , Shimakawa S , et al. Clinico-radiological spectrum of reversible splenial lesions in children[J]. Brain Dev, 2014, 36 (4): 330- 336. doi: 10.1016/j.braindev.2013.05.007
14	Ka A , Britton P , Troedson C , et al. Mild encephalopathy with reversible splenial lesion: An important differential of encephalitis[J]. Eur J Paediatr Neurol, 2015, 19 (3): 377- 382. doi: 10.1016/j.ejpn.2015.01.011
15	Tada H , Takanashi J , Barkovich AJ , et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion[J]. Neurology, 2004, 63 (10): 1854- 1858. doi: 10.1212/01.WNL.0000144274.12174.CB
16	Takanashi J . Two newly proposed infectious encephalitis/encephalopathy syndromes[J]. Brain Dev, 2009, 31 (7): 521- 528. doi: 10.1016/j.braindev.2009.02.012
17	Takanashi J , Imamura A , Hayakawa F , et al. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)[J]. J Neurol Sci, 2010, 292 (1/2): 24- 27.
18	Starkey J , Kobayashi N , Numaguchi Y , et al. Cytotoxic lesions of the corpus callosum that show restricted difusion: Mechanisms, causes, and manifestations[J]. Radiographics, 2017, 37 (2): 562- 576. doi: 10.1148/rg.2017160085
19	Takanashi J , Tada H , Maeda M , et al. Encephalopathy with a reversible splenial lesion is associated with hyponatremia[J]. Brain Dev, 2009, 31 (3): 217- 220. doi: 10.1016/j.braindev.2008.04.002
20	Watanabe T , Abe Y , Sato S , et al. Hyponatremia in Kawasaki disease[J]. Pediatr Nephrol, 2006, 21 (6): 778- 781. doi: 10.1007/s00467-006-0086-6
21	Rife E , Gedalia A . Kawasaki Disease: An Update[J]. Curr Rheumatol Rep, 2020, 22 (10): 75. doi: 10.1007/s11926-020-00941-4
22	Terai M , Honda T , Yasukawa K , et al. Prognostic impact of vascular leakage in acute Kawasaki disease[J]. Circulation, 2003, 108 (3): 325- 330. doi: 10.1161/01.CIR.0000079166.93475.5F
23	Miyata R , Tanuma N , Hayashi M , et al. Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)[J]. Brain Dev, 2012, 34 (2): 124- 127. doi: 10.1016/j.braindev.2011.04.004
24	Ichiyama T , Nishikawa M , Hayashi T , et al. Cerebral hypoperfusion during acute Kawasaki disease[J]. Stroke, 1998, 29 (7): 1320- 1321. doi: 10.1161/01.STR.29.7.1320
25	Hikita T , Kaminaga T , Wakita S , et al. Regional cerebral blood flow abnormalities in patients with kawasaki disease[J]. Clin Nucl Med, 2011, 36 (8): 643- 649. doi: 10.1097/RLU.0b013e318217adfc
26	多田弘子, 高梨潤一. 可逆性脳梁膨大部病変を有する軽症脳炎脳症―up-to-date[J]. 日本小児科学会雑誌, 2019, 123 (5): 814- 823.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

[1]	李宗瀚, 黄洋阅, 李宁, 李明磊, 宋宏程, 张潍平, 刘超. 国产单孔蛇形臂机器人手术系统在儿童肾盂成形术中的应用[J]. 北京大学学报（医学版）, 2025, 57(4): 662-665.
[2]	赵兆, 张维宇, 杨文博, 张勇杰, 张晓鹏, 赵慧颖, 周刚, 王强. 低龄、低体重儿童肾移植2例[J]. 北京大学学报（医学版）, 2025, 57(4): 803-807.
[3]	张依航, 蔡珊, 陈子玥, 刘云飞, 党佳佳, 师嫡, 李佳欣, 黄天彧, 宋逸. 基于RE-AIM框架儿童青少年近视与肥胖共病综合干预实施性研究结局指标的构建[J]. 北京大学学报（医学版）, 2025, 57(3): 436-441.
[4]	唐孟利, 刘扬, 秦冉, 郭欣, 李宏田. 我国10省幼儿园5~6岁儿童近视和近视前期流行特征[J]. 北京大学学报（医学版）, 2025, 57(3): 442-447.
[5]	刘光旭, 张良, 赵厚宇, 邓思危, 杨君婷, 李宁, 马瑞, 何艳, 许国章, 刘志科, 詹思延. 2015—2021年宁波市6岁以下儿童热性惊厥的流行病学特征[J]. 北京大学学报（医学版）, 2025, 57(3): 584-591.
[6]	李琳, 廖津津. 应用ROC曲线评估久坐行为对儿童青少年视力不良的预测价值[J]. 北京大学学报（医学版）, 2025, 57(3): 614-619.
[7]	王紫薇, 李闵, 高慧, 邓芳. 链球菌感染与过敏性紫癜肾炎患儿肾损害的相关性[J]. 北京大学学报（医学版）, 2025, 57(2): 284-290.
[8]	邓敏婷, 王楠, 夏斌, 赵玉鸣, 朱俊霞. 儿童及青少年挫入恒前牙自行再萌出的相关影响因素[J]. 北京大学学报（医学版）, 2025, 57(1): 148-153.
[9]	杨颖婷, 李若竹, 窦桂丽, 雷玥, 夏斌. iRoot BP Plus用于年轻恒牙外伤部分牙髓切断治疗的临床随机对照研究[J]. 北京大学学报（医学版）, 2024, 56(6): 1083-1088.
[10]	赵双云, 邹思雨, 李雪莹, 沈丽娟, 周虹. 中文版口腔健康素养量表简版(HeLD-14)在学龄前儿童家长中应用的信度和效度评价[J]. 北京大学学报（医学版）, 2024, 56(5): 828-832.
[11]	陈心心, 唐哲, 乔艳春, 荣文笙. 北京市密云区4岁儿童患龋状况及其与龋活跃性检测的相关性[J]. 北京大学学报（医学版）, 2024, 56(5): 833-838.
[12]	岳芷涵,韩娜,鲍筝,吕瑾莨,周天一,计岳龙,王辉,刘珏,王海俊. 儿童早期体重指数轨迹与超重风险关联的前瞻性队列研究[J]. 北京大学学报（医学版）, 2024, 56(3): 390-396.
[13]	费秀文,刘斯,汪波,董爱梅. 成人及儿童组织坏死性淋巴结炎临床特征及治疗[J]. 北京大学学报（医学版）, 2024, 56(3): 533-540.
[14]	俞光岩. 儿童唾液腺疾病[J]. 北京大学学报（医学版）, 2024, 56(1): 1-3.
[15]	闫晓晋,刘云飞,马宁,党佳佳,张京舒,钟盼亮,胡佩瑾,宋逸,马军. 《中国儿童发展纲要(2011-2020年)》实施期间中小学生营养不良率变化及其政策效应分析[J]. 北京大学学报（医学版）, 2023, 55(4): 593-599.